Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
NeonMind Advances Strategy for Specialty Clinic Launch Company expects to launch first specialty clinic locations by early 2022 NeonMind-branded specialty mental health clinics to bring innovative...
NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo Vazquez, MD, PhD. Company Continues to...
NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board Company Broadens Scientific Expertise with Addition of Mental Health Expert in...
NeonMind to Present at H.C. Wainwright 23rd Annual Global Investment ConferenceVancouver, B.C. - September 8, 2021: NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) (FFE: 6UF) ("NeonMind'' or...
Dr. Sagar Parikh, MD Appointed to NeonMind Specialty Clinics Advisory Board Vancouver, B.C. – July 28, 2021 -- InvestorsHub NewsWire -- NeonMind Biosciences Inc. (CSE:...
NeonMind Announces Launch of Functional Mushroom Coffees as Dietary Supplements in the US Vancouver, B.C., Canada -- June 29, 2021 -- InvestorsHub NewsWire -- NeonMind Biosciences Inc. (CSE:...
NeonMind Announces Vitasave Will Carry NeonMind Functional Mushroom Products Vancouver, B.C. - June 9, 2021 -- InvestorsHub NewsWire -- NeonMind Biosciences Inc. (CSE: NEON) (OTC:NMDBF) (FRA: 6UF...
NeonMind to Commence Trading on the OTCQB Venture MarketVancouver, B.C. - May 28, 2021 -- InvestorsHub NewsWire -- NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) (FFE: 6UF) ("NeonMind"), an...
NeonMind Developing Music Playlist for Psychedelic Therapy Sessions Vancouver, B.C. – April 6, 2021 -- InvestorsHub NewsWire -- NeonMind Biosciences Inc. (CSE: NEON) (FFE:...
NeonMind Engages Pharma Executive Philippe Martin to Advance its Psilocybin Drug Candidates for Obesity Vancouver, B.C. - March 9, 2021: NeonMind Biosciences Inc. (CSE: NEON) (OTC: NMDBF) (FRA:...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.3 | 0.3 | 0.3 | 0 | 0 | CS |
| 4 | 0 | 0 | 0.3 | 0.3 | 0.3 | 0 | 0 | CS |
| 12 | 0 | 0 | 0.3 | 0.3 | 0.3 | 0 | 0 | CS |
| 26 | 0 | 0 | 0.3 | 0.3 | 0.3 | 0 | 0 | CS |
| 52 | 0 | 0 | 0.3 | 0.3 | 0.3 | 0 | 0 | CS |
| 156 | 0.245 | 445.454545455 | 0.055 | 0.3 | 0.005 | 18411 | 0.04333092 | CS |
| 260 | -0.05 | -14.2857142857 | 0.35 | 0.35 | 0.005 | 115233 | 0.20582625 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
